Patents by Inventor Ki-Bong Oh

Ki-Bong Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240145263
    Abstract: According to an aspect of the present disclosure, there is provided a substrate treating apparatus comprising: a vessel part having a substrate treatment region formed therein and including a supply port through which a treating fluid is supplied to the substrate treatment region and an exhaust port through which the treating fluid is exhausted from the substrate treatment region; a fluid supply unit configured to supply the treating fluid to the substrate treatment region; an exhaust unit configured to exhaust the treating fluid from the vessel part. The exhaust unit comprises: a main line connected to the exhaust port; an extension line branched from at least one of first and second nodes of the main line and including at least one of a first orifice or a first check valve to control an exhaust speed; and an auxiliary line branched from a third node of the main line, where an orifice and a check valve are not formed.
    Type: Application
    Filed: January 20, 2023
    Publication date: May 2, 2024
    Inventors: Seung Hoon OH, Ki Bong KIM, Jong Doo LEE, Young Hun LEE, Mi So PARK, Jin Se PARK, Yong Sun KO
  • Patent number: 10759831
    Abstract: Provided are a novel peptide compound, a method of producing the same, and use of the peptide compound. Since the peptide compound has anticancer activity, the peptide compound may be used for the prevention or treatment of cancer.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: September 1, 2020
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Jong Heon Shin, Ki Bong Oh, Dong Chan Oh, Sang Kook Lee, Lijuan Liao, Min Jung You
  • Publication number: 20200190140
    Abstract: Provided are a novel peptide compound, a method of producing the same, and use of the peptide compound. Since the peptide compound has anticancer activity, the peptide compound may be used for the prevention or treatment of cancer.
    Type: Application
    Filed: February 28, 2020
    Publication date: June 18, 2020
    Inventors: Jong Heon Shin, Ki Bong Oh, Dong Chan Oh, Sang Kook Lee, Lijuan Liao, Min Jung You
  • Patent number: 10618934
    Abstract: Provided are a novel peptide compound, a method of producing the same, and use of the peptide compound. Since the peptide compound has anticancer activity, the peptide compound may be used for the prevention or treatment of cancer.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: April 14, 2020
    Assignee: iNtRON Biotechnology, Inc.
    Inventors: Jong Heon Shin, Ki Bong Oh, Dong Chan Oh, Sang Kook Lee, Lijuan Liao, Min Jung You
  • Publication number: 20180079780
    Abstract: Provided are a novel peptide compound, a method of producing the same, and use of the peptide compound. Since the peptide compound has anticancer activity, the peptide compound may be used for the prevention or treatment of cancer.
    Type: Application
    Filed: October 23, 2015
    Publication date: March 22, 2018
    Inventors: Jong Heon Shin, Ki Bong Oh, Dong Chan Oh, Sang Kook Lee, Lijuan Liao, Min Jung You
  • Patent number: 6271267
    Abstract: A method for regulating the morphological transition of dimorphic Candida in a patient is described. The method comprises administering orally or by injection a compound to a patient suffering from an infection caused by dimorphic Candida selected from the group consisting of Candida albicans, Candida stellatoidea, Candida tropicalis, Candida grabrata, and Candida parapsilosis.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: August 7, 2001
    Assignee: Bio-Giken, Inc.
    Inventors: Hideaki Matsuoka, Ki-Bong Oh